Hedge Funds Are Selling VIVUS, Inc. (VVUS)

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
MannKind Corporation (NASDAQ:MNKD) 6 2 2
PDL BioPharma Inc. (NASDAQ:PDLI) 13 0 0
Sarepta Therapeutics Inc (NASDAQ:SRPT) 19 0 1
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) 9 0 0
Santarus, Inc. (NASDAQ:SNTS) 15 1 14

With the returns demonstrated by the aforementioned strategies, everyday investors should always watch hedge fund and insider trading sentiment, and VIVUS, Inc. (NASDAQ:VVUS) applies perfectly to this mantra.

Click here to learn why you should track hedge funds